InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
16,978.00
(
0.00%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.34
(
0.21%
)
Bitcoin
64,314.45
(
-0.26%
)
Post# of 251604
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 234635

Tuesday, 09/15/2020 12:06:31 PM

Tuesday, September 15, 2020 12:06:31 PM

Post# of 251604

RVNC—Could you see that [a buyout] happening before their [Daxi] PDUFA?

Probably not, but it’s conceivable that a deal would include a CVR for FDA approval of Daxi.

Realistically, the risk of Daxi non-approval is limited to CMC issues insofar as the BLA’s clinical dataset for glabellar lines is blemish-free.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up